Cardinal Health, Inc. $CAH Shares Bought by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 81.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 116,000 shares of the company’s stock after purchasing an additional 52,200 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Cardinal Health were worth $24,512,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Vanguard Group Inc. lifted its position in Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after buying an additional 617,775 shares during the last quarter. State Street Corp increased its position in shares of Cardinal Health by 1.8% during the fourth quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after acquiring an additional 221,497 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Cardinal Health by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after acquiring an additional 43,924 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after acquiring an additional 3,511,579 shares during the period. Finally, Norges Bank purchased a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $790,344,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.1%

Cardinal Health stock opened at $238.79 on Friday. The firm has a market cap of $55.93 billion, a PE ratio of 36.51, a price-to-earnings-growth ratio of 1.17 and a beta of 0.49. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $240.93. The company’s 50 day moving average is $208.99 and its two-hundred day moving average is $211.70.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.50%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Bank of America lifted their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a report on Thursday. Zacks Research cut Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Citigroup restated a “buy” rating on shares of Cardinal Health in a research report on Thursday. Morgan Stanley lifted their price objective on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Finally, JPMorgan Chase & Co. cut their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $247.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.